LB-100 Uses, Dosage, Side Effects and more
LB-100 is under investigation in clinical trial NCT03886662 (A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)).
| Trade Name | LB-100 |
| Generic | LB-100 |
| Type | |
| Formula | C13H20N2O4 |
| Weight | Average: 268.313 Monoisotopic: 268.142307132 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
